. Epidemiological pattern, incidence and outcomes of COVID-19 in liver transplant patients [published online ahead of print, 2020 Aug 1]. J Hepatol. 2020;S0168-8278(20)30521-3. doi:10.1016/j.jhep.2020.07.040.F.I:20.582.
Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey. Respir Med. 2020;170:106062. doi:10.1016/j.rmed.2020.106062.F.I.:3.095
La inflamación, la desnutrición y la infección por SARS-CoV-2: una combinación nefasta [Inflammation, malnutrition, and SARS-CoV-2 infection: a disastrous combination] [published online ahead of print, 2020 Aug 24]. Rev Clin Esp. 2020;10.1016/j.rce.2020.07.007. doi:10.1016/j.rce.2020.07.007. F.I.:1.304
Proteinosos alveolar pulmonar. Revista Española de Patología Torácica.2020;Vol 32,(2):125-134. 2020.F.I.:
Analysis of the Impact of Commercialized Hybrid Closed-Loop System on Glycemic Control, Glycemic Variability, and Patient-Related Outcomes in Children and Adults: A Focus on Superiority Over Predictive Low-Glucose Suspend Technology [published online ahead of print, 2020 Aug 28]. Diabetes Technol Ther. 2020;10.1089/dia.2019.0400. doi:10.1089/dia.2019.0400.F.I.:4.392
Burnout syndrome in internal medicine specialists and factors associated with its onset. Rev Clin Esp. 2020;220(6):331-338.F.I: 1.304
Biomecánica de la artrosis asimétrica del tobillo. Posibilidades de Cirugía de Preservación Articular. Mon. Act. 2020. Núm. 12. DOI:10.24129/j.mact.1201.fs2005001.Referencia impresa: Mon Act Soc Esp Med Cir Pie Tobillo. 2020;12:3-8. F.I.:
Systematic Review of the Impact of Drugs on Diffuse Interstitial Lung Disease Associated with Rheumatoid Arthritis. Reumatol Clin. 2020 Jun 19:S1699-258X(20)30111-X. English, Spanish. doi: 10.1016/j.reuma.2020.04.015. Epub ahead of print. PMID: 32571732.F.I.: 0.256
P1099 EVALUATION OF THE DEPURATION OF SOLUTES IN THE MIDDLE TO HIGH MOLECULAR WEIGHT RANGE WITH DIFFERENT TECHNIQUES OF HAEMODIALYSIS, Nephrology Dialysis Transplantation, Volume 35, Issue Supplement_3, June 2020, gfaa142.P1099, https://doi.org/10.1093/ndt/gfaa142.P1099
Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study Group . Ophthalmology. 2020 Jun;127(6):814-825. doi: 10.1016/j.ophtha.2019.11.024. Epub 2019 Dec 2. PMID: 31952883. F.I.: 1.650